Delivery Order SPE2DB22D3501-SPE2DB25FXH40
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4 gm units. This firm fixed price delivery order, valued at $2,640.52, is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order is scheduled for completion by September 5, 2025, with performance at the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,322.94 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhaler (4 grams) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed price delivery order represents a non-competitive set-aside procurement and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,917.50 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation medication (4 grams) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through open competition. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4-gram quantities, with a ceiling value of $1,277.09. This firm fixed-price delivery order, which must be completed by August 15, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,107.10 to AmerisourceBergen Drug Corp on August 6, 2025, for Spiriva Respimat 1.25 mcg inhaler 4gm, a respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, is scheduled for completion by August 7, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The order represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhaler (4 grams) with a ceiling value of $4,633.86. This firm fixed price, non-set-aside delivery order is scheduled for completion by September 12, 2025, and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal healthcare systems. The work will be performed at the company's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,860.74 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 2.5 mcg inhaler (4 grams) on September 15, 2025, with completion scheduled for September 16, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Spiriva Respimat 2.5 mcg inhalation medication in a 4-gram formulation. This competitively awarded, non-set-aside contract carries a ceiling value of $2,680.75 and a firm fixed price structure, with an ultimate completion date of September 9, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,844.50 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 1.25 mcg inhalation solution (4 gm). This competitively awarded, firm fixed-price contract has a completion date of June 11, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SPIRIVA RESPIMAT 2.5 MCG inhalation medication in a 4 GM formulation, with a ceiling value of $1,779.64. This competitively awarded, firm fixed-price delivery order was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXH40Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Spiriva Respimat 2.5 mcg inhaler (4 grams) with a ceiling value of $1,629.61. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract is scheduled for completion by September 15, 2025, with fulfillment from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a prime value of $999,999,999.00 and runs through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Conshohocken and serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The underlying SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a vast range of medications, vaccines, and medical supplies across multiple therapeutic domains to federal customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for the respiratory medication aligns with AmerisourceBergen's extensive portfolio of federal pharmaceutical deliveries, which typically involve firm fixed-price arrangements and range from small-value transactions to orders exceeding $45,000, demonstrating the company's capability to fulfill varied federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/12/25 |